CAN LIVE BACTERIA BREAK THE IBS STRESS CYCLE?
As scientists are discovering more about the effects of microbiota on the digestive system and gut-brain axis, nutrition expert Miguel Toribio-Mateas highlights how high doses of live bacteria can help to break what is referred to as the ‘IBS stress cycle’.
“We now know that a balanced healthy gut flora can have a positive effect not just on our physical health but also our mental wellbeing[i] transforming the way we treat gastrointestinal conditions, such as IBS” explains nutrition practitioner and doctoral researcher in clinical neuroscience Miguel Toribio-Mateas. Miguel chairs the British Association for Nutrition and Lifestyle Medicine (BANT).
The negative impact of IBS on wellbeing was highlighted in a recent survey[ii] which revealed that the symptoms of IBS, including abdominal pain, bloating, flatulence and changes in toilet habits, have a profound effect on quality of life impacting on work, sex life and sleep.
IBS is thought to be caused by an imbalance of the 100 trillion bacteria that live in the gut and it is now known that a decreased gut-microbiota richness and diversity can also directly impact on mental wellbeing[iii]. “Supercharging the gut with high doses of specific types of healthy live bacteria can help restore a balanced gut flora providing long-term relief from the symptoms of IBS and breaking the IBS stress cycle” adds Miguel.
VSL#3, is a freeze-dried poly-biotic* containing the highest concentration of good bacteria.[iv] It is clinically proven to relieve IBS symptoms including abdominal pain, bloating and flatulence within just 4-8 weeks, helping to restore quality of life[v],[vi],[vii],[viii] for the 1 in 5 who suffer from IBS[ix]. VSL#3 contains eight strains of beneficial live bacteria and works by delivering a high volume of good bacteria that are proven to survive the harsh conditions of the stomach allowing them to reach and colonise the gut where they restore a healthy balance.[x]
Having suffered from IBS since she was 18, Jill (in her early 40s) reveals, “The bloating and discomfort of IBS really affected my daily life, often stopping me going out. Changes to bowel habits also made me lethargic, leaving me feeling more stressed and downhearted. Unlike other probiotics I have taken, since adding VSL#3 to my daily routine, I started to see significant improvement with my symptoms within literally a few days and I couldn’t be happier with the results.”
VSL#3 is something I have added into my routine for the past month, although I don’t suffer from IBS, I am in the process of treating ‘leaky gut’ syndrome. I was diagnosed with this due to the skin issues I have suffered with for years (some since birth), such as eczema and KP, as well as asthma and other allergies. After recently speaking to a physician I have put on a programme and part of this programme included VSL#3. . . more to come on this later.
Help restore your balance with VSL#3:
- Clinically proven – supported by Level One (double-blind, placebo-controlled) scientific data with over 170 published studies.[i]
- Relieves key IBS symptoms – proven to relieve debilitating IBS symptoms, including abdominal pain intensity and duration, bloating, and flatulence, helping to improve the quality of life of sufferers, in 4 – 8 weeks.[ii],[iii],[iv],[v]
- Rebalances gut flora – contains 450 billion bacteria per sachet purposely selected, carefully cultivated and mixed proportionally to survive gastric acid, bile, and pancreatic secretions, allowing them to reach and colonise the gut.[vi]
*Polybiotics and Probiotics – both food supplements contain ‘friendly’ or good bacteria in varying quantities to help rebalance the gut flora and promote a healthy digestive system
[ii] Kim HJ et al. Aliment Pharmacol Ther. 2003; 17: 895-904
[iii] Kim HJ et al. Neurogastroenterol Motil. 2005; 17: 687 -96
[iv] Wong RK et al. Dig Dis Sci. 2015; 60 (1): 186-94
[v] De Boer. AGA Abstract 2012.
[vi] Fredua-Agyeman, M& Gaisford S (2014) Comparative survival of commercial probiotic formulations. UCL Study. Beneficial Microbes 2015. 6 (1): 141-151
[i] Dinan T.G, Cryan J.F Brain-gut-microbiota axis – mood, metabolism and behaviour. Nature Reviews: Gastroenterology & Hepatology 2017
[ii] IBS Network Survey 2017
[iii] Dinan T.G, Cryan J.F, Brain-gut-microbiota axis. Nature Reviews. Gastroenterology & Hepatology 2017
[iv] Data on file – Ferring
[v] Kim HJ et al. Aliment Pharmacol Ther. 2003; 17: 895-904
[vi] Kim HJ et al. Neurogastroenterol Motil. 2005; 17: 687 -96
[vii] Wong RK et al. Dig Dis Sci. 2015; 60 (1): 186-94
[viii] De Boer. AGA Abstract 2012
[x] Fredua-Agyeman, M& Gaisford S (2014) Comparative survival of commercial probiotic formulations. UCL Study. Beneficial Microbes 2015. 6 (1): 141-151